|Articles|March 1, 2004
- Pharmaceutical Executive-03-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
DTC: European Styleover 22 years ago
The Ins and Outs of EAPsover 22 years ago
Is Everyone a Target?over 22 years ago
The Push for Modern ManufacturingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5